Overexpression of JAM-A in non-small cell lung cancer correlates with tumor progression

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Zhang, Min ^a,b   Luo, Wenting ^a   Huang, Bo ^c   Liu, Zihui ^a   Sun, Limei ^a   Zhang, Qingfu ^a   Qiu, Xueshan ^a   Xu, Ke ^a   Wang, Enhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG MEDICAL COLLEGE   (China)

^c LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MALE; RECEPTORS, CELL SURFACE;

EID: 84893404644     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079173     Document Type: Article

References (30)

1. Liu Y, Nusrat A, Schnell FJ, Reaves TA, Walsh S, et al. (2000) Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 113 (Pt 13): 2363-2374. (Pubitemid 30599341)
2. Liang TW, DeMarco RA, Mrsny RJ, Gurney A, Gray A, et al. (2000) Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation. Am J Physiol Cell Physiol 279: C1733-1743.
3. Del MA, De Luigi A, Martin-Padura I, Brockhaus M, Bartfai T, et al. (1999) Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med 190: 1351-1356. (Pubitemid 29522218)
4. Gupta SK, Pillarisetti K, Ohlstein EH (2000) Platelet agonist F11 receptor is a member of the immunoglobulin superfamily and identical with junctional adhesion molecule (JAM): regulation of expression in human endothelial cells and macrophages. IUBMB Life 50: 51-56.
5. Martin-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, et al. (1998) Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 142: 117-127. (Pubitemid 28341144)
6. Bradfield PF, Nourshargh S, Aurrand-Lions M, Imhof BA (2007) JAM family and related proteins in leukocyte migration (Vestweber series). Arterioscler Thromb Vasc Biol 27: 2104-2112. (Pubitemid 350287237)
7. Malergue F, Galland F, Martin F, Mansuelle P, Aurrand-Lions M, et al. (1998) A novel immunoglobulin superfamily junctional molecule expressed by antigen presenting cells, endothelial cells and platelets. Mol Immunol 35: 1111-1119. (Pubitemid 29057150)
8. Sobocka MB, Sobocki T, Banerjee P, Weiss C, Rushbrook JI, et al. (2000) Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation. Blood 95: 2600-2609. (Pubitemid 30210539)
9. Kornecki E, Walkowiak B, Naik UP, Ehrlich YH (1990) Activation of human platelets by a stimulatory monoclonal antibody. J Biol Chem 265: 10042-10048.
10. Naik MU, Mousa SA, Parkos CA, Naik UP (2003) Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex. Blood 102: 2108-2114. (Pubitemid 37122387)
11. Barton ES, Forrest JC, Connolly JL, Chappell JD, Liu Y, et al. (2001) Junction adhesion molecule is a receptor for reovirus. Cell 104: 441-451. (Pubitemid 32206464)
12. Mandell KJ, McCall IC, Parkos CA (2004) Involvement of the junctional adhesion molecule-1 (JAM1) homodimer interface in regulation of epithelial barrier function. J Biol Chem 279: 16254-16262. (Pubitemid 38509319)
13. Bazzoni G, Martinez-Estrada OM, Orsenigo F, Cordenonsi M, Citi S, et al. (2000) Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem 275: 20520-20526. (Pubitemid 30457633)
14. Ebnet K, Schulz CU, Meyer ZBMK, Pendl GG, Vestweber D (2000) Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem 275: 27979-27988.
15. Ebnet K, Suzuki A, Horikoshi Y, Hirose T, Meyer ZBMK, et al. (2001) The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM). EMBO J 20: 3738-3748. (Pubitemid 32691785)
16. Severson EA, Jiang L, Ivanov AI, Mandell KJ, Nusrat A, Parkos CA (2008) Cisdimerization mediates function of junctional adhesion molecule A. Mol Biol Cell 19: 1862-1872.
17. Severson EA, Lee WY, Capaldo CT, Nusrat A, Parkos CA (2009) Junctional adhesion molecule A interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate beta1 integrin levels, and enhance cell migration. Mol Biol Cell 20: 1916-1925.
18. Naik MU, Naik TU, Suckow AT, Duncan MK, Naik UP (2008) Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion. Cancer Res 68: 2194-2203. (Pubitemid 351521792)
19. Koshiba H, Hosokawa K, Kubo A, Tokumitsu N, Watanabe A, Honjo H (2009) Junctional adhesion molecule A [corrected] expression in human endometrial carcinoma. Int J Gynecol Cancer 19: 208-213.
20. Fong D, Spizzo G, Mitterer M, Seeber A, Steurer M, et al. (2012) Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer. Ann Surg Oncol 19: 4330-4336.
21. McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, et al. (2009) JAM-A expression positively correlates with poor prognosis in breast cancer patients. Int J Cancer 125: 1343-1351.
22. Murakami M, Giampietro C, Giannotta M, Corada M, Torselli I, et al. (2011) Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression. PLoS One 6: e21242.
23. McSherry EA, Brennan K, Hudson L, Hill AD, Hopkins AM (2011) Breast cancer cell migration is regulated through junctional adhesion molecule-Amediated activation of Rap1 GTPase. Breast Cancer Res 13: R31.
24. Brennan K, McSherry EA, Hudson L, Kay EW, Hill AD, et al. (2013) Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling. Oncogene 32: 2799-2804.
25. Gotte M, Mohr C, Koo CY, Stock C, Vaske AK, et al. (2010) miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness. Oncogene 29: 6569-6580.
26. Goetsch L, Haeuw JF, Beau-Larvor C, Gonzalez A, Zanna L, et al. (2013) A novel role for junctional adhesion molecule-A in tumor proliferation: modulation by an anti-JAM-A monoclonal antibody. Int J Cancer 132: 1463-1474.
27. Nava P, Capaldo CT, Koch S, Kolegraff K, Rankin CR, et al. (2011) JAM-A regulates epithelial proliferation through Akt/beta-catenin signalling. EMBO Rep 12: 314-320.
28. Giacinti C, Giordano A (2006) RB and cell cycle progression. Oncogene 25: 5220-5227. (Pubitemid 44299080)
29. Khidr L, Chen PL (2006) RB, the conductor that orchestrates life, death and differentiation. Oncogene 25: 5210-5219. (Pubitemid 44299079)
30. Harbour JW, Dean DC (2000) The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 14: 2393-2409.